Bioadaptives, INC. (BDPT) — 10-Q Filings

10-Q Filings (6)

• BioAdaptives' Losses Mount Amid Soaring Expenses, Cash Dwindles — Nov 14, 2025 Risk: high
  BIOADAPTIVES, INC. (BDPT) reported a significant increase in net loss for the nine months ended September 30, 2025, reaching $734,552, up from $527,373 in the p
• BioAdaptives Narrows Q2 Loss, Raises Capital Amid Going Concern Doubts — Aug 14, 2025 Risk: high
  BioAdaptives, Inc. (BDPT) reported a net loss of $157,914 for the three months ended June 30, 2025, an improvement from a net loss of $183,017 in the same perio
• BioAdaptives Q1 2025: $9M Revenue, $125M Assets — May 13, 2025 Risk: medium
  BioAdaptives, Inc. filed its Q1 2025 10-Q report for the period ending March 31, 2025. The company reported revenue of $9,048,659. Key financial figures include
• BioAdaptives, Inc. Q3 2024 10-Q Filing — Nov 19, 2024 Risk: medium
  BioAdaptives, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported total assets of $1,250,000,000 and total liabilities of $895,76
• BioAdaptives Reports Q2 2024 Results — Aug 19, 2024 Risk: medium
  BioAdaptives, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported total assets of $1.25 billion and total liabilities of $895.8 millio
• BioAdaptives Q1 2024: Assets $1.15B, Liabilities $895M — May 17, 2024 Risk: medium
  BioAdaptives, Inc. filed its 10-Q for the period ending March 31, 2024. The company reported total assets of $1,154,770,641 and total liabilities of $895,760,22

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX